Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Nir, Eyal"'
Autor:
Ilona Fridman, Nir Eyal, Karen A. Scherr, Judith S. Currier, Kenneth A. Freedberg, Scott D. Halpern, Daniel R. Kuritzkes, Monica Magalhaes, Kathryn I. Pollak, Peter A. Ubel
Publikováno v:
AIDS Research and Therapy, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background In the US, 1.2 million people live with HIV (PWH). Despite having near-normal life expectancies due to antiretroviral therapy (ART), many PWH seek an HIV cure, even if it means risking their lives. This willingness to take risks f
Externí odkaz:
https://doaj.org/article/edd35a3a229b4ed2a85581267c89f6d4
Publikováno v:
mSphere, Vol 9, Iss 7 (2024)
ABSTRACT U.S. regulation of dual-use research of concern and of research with enhanced pathogens of pandemic potential may alter soon. Much has been written on the best form for that regulation to take. Less was written on a procedural question: whos
Externí odkaz:
https://doaj.org/article/1389f3d4f8014987ac5e3d3f11dfa36b
Autor:
Amirhossein Takian, Arefeh Mousavi, Martin McKee, Vahid Yazdi-Feyzabadi, Ronald Labonté, Viroj Tangcharoensathien, Ruairí Brugha, Elizabeth Bradley, Lawrence Gostin, Eivind Engebretsen, Nir Eyal, Sharon Friel, Victor G. Rodwin, Ole F. Norheim, Mohammad Hajizadeh, Naoki Ikegami, Agnes Binagwaho, Ilona Kickbusch, Aidin Aryankhesal, Ali-Akbar Haghdoost
Publikováno v:
International Journal of Health Policy and Management, Vol 11, Iss 12, Pp 2776-2779 (2022)
In line with the global trend, the Middle East and North Africa (MENA) region has been growing vulnerable to the direct and indirect health effects of climate change including death tolls due to climatological disasters and diseases sensitive to clim
Externí odkaz:
https://doaj.org/article/44af8e92052a4d5b92f627352226a580
Publikováno v:
Journal of Virus Eradication, Vol 8, Iss 3, Pp 100084- (2022)
Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity,
Externí odkaz:
https://doaj.org/article/ba3d0be3fc9d4a0db364f45b13a41458
Of every thousand children born in Iceland, two will die before their first birthday, but in Mozambique the death rate is sixty times higher. Even within countries - including some of the wealthiest - inequalities in longevity and health can be subst
Autor:
Snodin, Benedict E. K., Randisi, Ferdinando, Mosayebi, Majid, Sulc, Petr, Schreck, John S., Romano, Flavio, Ouldridge, Thomas E., Tsukanov, Roman, Nir, Eyal, Louis, Ard A., Doye, Jonathan P. K.
Publikováno v:
J. Chem. Phys. 142, 234901 (2015)
We introduce an extended version of oxDNA, a coarse-grained model of DNA designed to capture the thermodynamic, structural and mechanical properties of single- and double-stranded DNA. By including explicit major and minor grooves, and by slightly mo
Externí odkaz:
http://arxiv.org/abs/1504.00821
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 307-311 (2021)
The design of human challenge studies balances scientific validity, efficiency and study safety. This Perspective explores some advantages and disadvantages of ‘low-dosage’ challenge studies, in the setting of testing second-generation vaccines a
Externí odkaz:
https://doaj.org/article/28f60edbbea2424a86617dff98c10a72
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/06c1056f74ea479eb0c7a202fcb46930
Autor:
Abigail A Marsh, Monica Magalhaes, Matthew Peeler, Sophie M Rose, Thomas C Darton, Nir Eyal, Josh Morrison, Seema K Shah, Virginia Schmit
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0275823 (2022)
In human challenge trials (HCTs), volunteers are deliberately infected with an infectious agent. Such trials can be used to accelerate vaccine development and answer important scientific questions. Starting early in the COVID-19 pandemic, ethical con
Externí odkaz:
https://doaj.org/article/570d54c917354cb8b99d16409773f7fe